Your session is about to expire
← Back to Search
Radiation Therapy
SBRT for Prostate Cancer (SOLAR-P Trial)
N/A
Waitlist Available
Led By Anand Swaminath, MD
Research Sponsored by Hamilton Health Sciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
SOLAR-P Trial Summary
This trial is testing a new, more focused form of radiation therapy to see if it can more effectively relieve pain from bone metastases in certain types of cancer.
Eligible Conditions
- Bone Metastases
- Prostate Cancer
- Breast Cancer
- Kidney Cancer
- Melanoma
SOLAR-P Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Acute Toxicity
Late Toxicity
Local Control
+3 moreSide effects data
From 2024 Phase 2 trial • 57 Patients • NCT0300418321%
Fatigue
13%
Nausea
11%
Back pain
9%
Shortness of Breath
9%
Anemia
9%
Abdominal pain
9%
Diarrhea
7%
Pneumonia
7%
Kidney Injury and/or Infection
7%
Dyspnea
7%
Weight Loss
5%
Malnutrition, Hypercalcemia and Weakness
5%
Pneumothorax
5%
Intractable pain, back pain, hip pain
5%
Activated partial thromboplastin time prolonged
4%
Pleural effusion
4%
Atrial fibrillation with rapid ventricular response
2%
Thrombocytopenia
2%
Respiratory failure
2%
Skin rash
2%
colitis
100%
80%
60%
40%
20%
0%
Study treatment Arm
Single Arm
SOLAR-P Trial Design
1Treatment groups
Experimental Treatment
Group I: Stereotactic Body RadiotherapyExperimental Treatment1 Intervention
High dose SBRT to lesion(s) of interest.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SBRT
2014
Completed Phase 2
~1060
Find a Location
Who is running the clinical trial?
Hamilton Health Sciences CorporationLead Sponsor
368 Previous Clinical Trials
300,961 Total Patients Enrolled
1 Trials studying Prostate Cancer
20 Patients Enrolled for Prostate Cancer
Juravinski Cancer Centre FoundationOTHER
11 Previous Clinical Trials
1,877 Total Patients Enrolled
Anand Swaminath, MDPrincipal InvestigatorHamilton Health Sciences Corporation
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the size of this particular experimental cohort?
"Affirmative. According to clinicaltrials.gov, the study is currently accepting applications from interested participants and was last revised on July 26th 2021 after first being posted on December 4th 2020. The medical trial is planning to enlist 40 patients at a single location."
Answered by AI
Are applications still being taken for this experiment?
"Correct. Records hosted on clinicaltrials.gov verify that this investigation, which was originally posted on December 4th 2020, is actively recruiting patients. Approximately 40 individuals ought to be enrolled from 1 clinic site."
Answered by AI
Share this study with friends
Copy Link
Messenger